2022 BPS coverage: Medications for inflammatory disease, diabetes account for top eligible drug costs
While medications used for treating inflammatory disease accounted for just 0.7 per cent of claims across Telus Health’s Canadian block of business in 2021, they represent the largest percentage of eligible drug costs at 12.6 per cent, due to the prevalence of high-cost treatments in this drug class. By comparison, diabetes medications accounted for 12 […]
- June 17, 2022 June 17, 2022
- 08:47